Literature DB >> 1540969

Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method.

C B Wilson1, A A Lammertsma, C G McKenzie, K Sikora, T Jones.   

Abstract

A noninvasive dynamic method for the measurement of blood flow, using 15O-labeled water and positron emission tomography, has been developed and used to study 20 patients with breast carcinoma. The mean tumor flow was 29.8 +/- 17.0 (SE) ml/dl/min of tissue, while normal breast flow was 5.6 +/- 1.4 ml/dl/min of tissue. The exchanging water space of tissue known as the volume of distribution of the tracer (Vd) was also derived. This is defined as the volume of water in tissue that exchanges with a unit volume of water in arterial blood during the period of the study (7 min). The mean tumor Vd was 0.56 +/- 0.15 ml/ml while normal breast Vd was 0.14 +/- 0.05 ml/ml. The low value in normal breast is partly due to the high fat content of the tissue. The mean flow per unit of exchangeable volume was similar in tumor (52.8 +/- 22.0) and normal breast tissue (45.2 +/- 20.0). This suggests that the major discrepancy seen in measured values of flow between breast tumors and normal breast principally reflects the different composition of the two tissues. This method is rapid and suited for studying the reactivity of human tumor vasculature, so extending studies are being performed on animal tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540969

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  Positron emission tomography (PET): expanding the horizons of oncology drug development.

Authors:  Lisa A Hammond; Louis Denis; Umber Salman; Paul Jerabek; Charles R Thomas; John G Kuhn
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

Review 2.  Use of positron emission tomography in anticancer drug development.

Authors:  Eric O Aboagye; Patricia M Price
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

Review 3.  FDG-PET in monitoring therapy of breast cancer.

Authors:  H-J Biersack; H Bender; H Palmedo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-27       Impact factor: 9.236

Review 4.  Radionuclide imaging of perfusion and hypoxia.

Authors:  George Laking; Pat Price
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

5.  Evaluation of basis function and linear least squares methods for generating parametric blood flow images using 15O-water and Positron Emission Tomography.

Authors:  Ronald Boellaard; Paul Knaapen; Abraham Rijbroek; Gert J J Luurtsema; Adriaan A Lammertsma
Journal:  Mol Imaging Biol       Date:  2005 Jul-Aug       Impact factor: 3.488

Review 6.  Current and future use of positron emission tomography (PET) in breast cancer.

Authors:  David A Mankoff; William B Eubank
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

7.  Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

Authors:  Betty S Pio; Cecilia K Park; Richard Pietras; Wei-Ann Hsueh; Nagichettiar Satyamurthy; Mark D Pegram; Johannes Czernin; Michael E Phelps; Daniel H S Silverman
Journal:  Mol Imaging Biol       Date:  2006 Jan-Feb       Impact factor: 3.488

Review 8.  Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring.

Authors:  Quing Zhu; Susan Tannenbaum; Scott H Kurtzman
Journal:  Surg Oncol Clin N Am       Date:  2007-04       Impact factor: 3.495

Review 9.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

10.  Dynamic functional and mechanical response of breast tissue to compression.

Authors:  S A Carp; J Selb; Q Fang; R Moore; D B Kopans; E Rafferty; D A Boas
Journal:  Opt Express       Date:  2008-09-29       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.